Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |